Paricalcitol Improves the Angiopoietin/Tie-2 and VEGF/VEGFR2 Signaling Pathways in Adriamycin-Induce...
Paricalcitol Improves the Angiopoietin/Tie-2 and VEGF/VEGFR2 Signaling Pathways in Adriamycin-Induced Nephropathy
About this item
Full title
Author / Creator
Deluque, Amanda Lima , Oliveira, Beatriz Magalhães , Souza, Cláudia Silva , Maciel, Ana Lívia Dias , Francescato, Heloísa Della Coletta , Giovanini, Cleonice , de Almeida, Lucas Ferreira , de Paula, Francisco José Albuquerque , Costa, Roberto Silva , Antunes-Rodrigues, José and Coimbra, Terezila Machado
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Renal endothelial cell (EC) injury and microvascular dysfunction contribute to chronic kidney disease (CKD). In recent years, increasing evidence has suggested that EC undergoes an endothelial-to-mesenchymal transition (EndoMT), which might promote fibrosis. Adriamycin (ADR) induces glomerular endothelial dysfunction, which leads to progressive pro...
Alternative Titles
Full title
Paricalcitol Improves the Angiopoietin/Tie-2 and VEGF/VEGFR2 Signaling Pathways in Adriamycin-Induced Nephropathy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9783872
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9783872
Other Identifiers
ISSN
2072-6643
E-ISSN
2072-6643
DOI
10.3390/nu14245316
